Clinical Trials Logo

Prevalence clinical trials

View clinical trials related to Prevalence.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05851820 Completed - COVID-19 Clinical Trials

Prevalence and Impact of Diabetes Mellitus in Hospitalized COVID-19 Patients in a Tunisian Center

Start date: September 25, 2020
Phase:
Study type: Observational

Objective: The objective of this study was to evaluate the prevalence and impact of diabetes mellitus on the severity and mortality of COVID-19. Methods: Data of laboratory-confirmed hospitalized patients at the COVID-19 unit of Ibn El Jazzar University Hospital in Kairouan between September 2020 and August 2021 were analysed, in a cross-sectional study. The population was classified into two groups (COVID-19 patients with versus without diabetes). Primary outcomes were the overall length of hospital stay, the admission to the intensive care unit (ICU), and death.

NCT ID: NCT05843760 Completed - Migraine Clinical Trials

Headache in Undergraduate Students and Biopsychosocial Status

Start date: May 4, 2023
Phase:
Study type: Observational [Patient Registry]

The primary aim of this study was to determine the prevalence of headache in undergraduate students. The frequency, duration, localizations and symptoms of headache will be determined with the information obtained as a result of the forms filled in by the participants. The second aim of this study is to examine the effects of headache on physical, social and psychological status in undergraduate student(participants) from a biopsychosocial perspective.

NCT ID: NCT05777096 Completed - Clinical trials for Musculoskeletal Disorders

Prevalence of Non-traumatic Musculoskeletal Disorders in the French Paragliding Pilots Population

EPPPAF
Start date: March 12, 2023
Phase:
Study type: Observational

The main objective is to determine the prevalence of non-traumatic pathologies in the paragliding population using the Nordic type questionnaire. The paragliding pilots population frequently evoque pathologies, discomfort, or pain in the course of their practice. Said pain and discomfort, though unerelated any form of accident, seem to have an impact on the pilots' flying and their participation in daily life. However, no epidemiological data are available in the literature. Investigators hypothesize the existence of non-traumatic disorders and it seems interesting to quantify the extent of the phenomenon. The results of this study might encourage the proposition of preventive measures in order to minimize a potential risk factor for paragliding accidents, and participation restrictions.

NCT ID: NCT05547646 Completed - Critical Care Clinical Trials

The Prevalence of Healthcare-associated Infection in Medical Intensive Care Units in Tunisia

NOSOREA2
Start date: September 27, 2022
Phase:
Study type: Observational

We aimed to determine the prevalence of HAI in medical Tunisian ICUs. Secondary endpoints were to identify the predominant infecting microorganisms and evaluate independent risk factors of HAIs.

NCT ID: NCT05002907 Completed - HIV Infections Clinical Trials

Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi)

MaHeVi
Start date: January 1, 2018
Phase:
Study type: Observational

MaHeVi is a multicenter, cross-sectional, population-based study which will include 2500 adults in the health care centers / missions located on the 2 sides of the Maroni River. All major inhabitants of the river border between French Guiana and Suriname may participate, after an extensive communication campaign.The main objective is to estimate the prevalence and status of infection with hepatitis B (HBV), hepatitis C (HCV), D (VHD) and HIV in the general adult population of the Maroni River, border between French Guiana and Suriname. After signing the informed consent and pre-test counseling, capillary blood will be collected on blotting paper. Participants will be interviewed on infection risk factors. Positivity for HBsAg, total anti-HBcAb, anti-HCV Ab, total anti-HDV Ab(for HBsAg positive) and HIV p24 Ag or anti-HIV Ab (confirmed by molecular biology for hepatitis and Western Blot for HIV) will inform respectively on the HBV, HCV, HDV and HIV infection status.

NCT ID: NCT04682938 Completed - Clinical trials for Adrenal Incidentaloma

The Prevalence and Characteristics of Adrenal Incidentaloma

Start date: November 20, 2020
Phase:
Study type: Observational

To investige the prevalence, characteristics and prognosis of adrenal incidentalomas in Chinese adults.

NCT ID: NCT04448769 Completed - Clinical trials for Coronavirus Infection

Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19)

COVAL-NANCY
Start date: June 26, 2020
Phase: N/A
Study type: Interventional

In order to inform the public decision on the containment strategy and knowledge of the intensity of the epidemic during post-containment, estimates of the share of the population infected with the SARS-CoV-2 virus responsible for COVID-19 disease at the territorial level are needed as soon as possible. The aim of the study is to estimate the prevalence of positive anti-SARS-CoV-2 serologies by detection of IgT-total antibodies (IgM/IgA/IgG) in the general population of the Grand Nancy Metropolitan area. A study of seroprevalence and symptom collection, or absence of symptoms, on a cluster (household) sample of the Grand Nancy Metropolitan population randomly selected will be conducted. The target population consists of all the inhabitants of the Grand Nancy Metropolitan area, from which a sample is drawn from the electoral lists (households) in a random manner to ensure representativeness. In order to ultimately include 2000 people in the study